U.S. Trade Distributors Stock News

Event context and recent stock performance Tarsus Pharmaceuticals (TARS) has attracted investor attention recently as its share price has moved over the past month and past 3 months, with the stock last closing at US$63.96 and a market value of about US$2.8b. See our latest analysis for Tarsus Pharmaceuticals. Zooming out, the stock’s recent share price returns, including a 6.98% 1 month decline and a 20.81% year to date decline, contrast with a 35.68% 1 year total shareholder return and very...

Enovis Corporation recently reported first-quarter 2026 results, with sales rising to US$589.15 million from US$558.83 million a year earlier and net loss narrowing to US$8.76 million from US$55.97 million, while basic and diluted loss per share from continuing operations improved to US$0.15 from US$0.98. The company also reaffirmed its full-year 2026 revenue guidance of about US$2.31 billion to US$2.37 billion, highlighting confidence in growth from its Reconstructive segment and new...

Xometry, Inc. reported Q1 2026 revenue of US$205.14 million, up from US$150.97 million a year earlier, while its net loss narrowed to US$5.27 million and basic loss per share improved to US$0.10. In parallel, Siemens agreed to invest about US$50,000,000 in Xometry and embed Xometry’s AI-powered manufacturing intelligence directly into the Siemens Xcelerator software suite, deepening Xometry’s integration into customers’ design and sourcing workflows. Next, we’ll examine how Siemens’...

Why NCR Atleos (NATL) is on investors’ radar NCR Atleos (NATL) has caught investor attention after its latest reported figures, showing revenue of US$4.4b and net income of US$170.0m, alongside a value score of 1 and recent share price moves. See our latest analysis for NCR Atleos. At a share price of US$44.25, NCR Atleos has seen an 18.86% year to date share price return and a 60.73% total shareholder return over the past year. This suggests momentum has been building as investors reassess...

IDACORP, Inc. reported past first-quarter 2026 results showing sales of US$402.76 million and net income of US$67.98 million, with diluted EPS from continuing operations of US$1.21, up from US$1.10 a year earlier. Alongside reaffirming its full-year 2026 earnings guidance of US$6.25 to US$6.45 per diluted share, the company expects Idaho Power to use less than US$30 million of additional tax credits under its Idaho regulatory mechanism, assuming normal weather and power supply expenses. We...

Why Ivanhoe Electric’s latest quarter is on investor radar Ivanhoe Electric (IE) returned to profitability in the first quarter of 2026, reporting net income of US$41.74 million compared with a net loss a year earlier, a shift that has drawn fresh attention to the stock. See our latest analysis for Ivanhoe Electric. The return to profit has arrived after a volatile period, with a 16.17% 1 month share price return and a 113.04% 1 year total shareholder return contrasting with weaker year to...

In 2025, VinFast Auto more than doubled its electric vehicle deliveries to 196,919 units and lifted e-scooter and e-bike deliveries to 406,498, surpassing its own guidance. This surge across both four-wheel and two-wheel segments, combined with a global 2026 EV delivery goal of 300,000 units, highlights how VinFast is scaling an integrated electric ecosystem rather than relying on a single product line. Now we’ll examine how this record delivery performance, especially in e-scooters and...

Why Silgan Holdings Is On Investors’ Radar Silgan Holdings (SLGN) has drawn fresh attention after recent share performance that includes a small gain over the past month alongside a decline over the past 3 months and the past year. See our latest analysis for Silgan Holdings. Silgan’s share price has eased back recently, with a 90 day share price return of a 17.65% decline and a 1 year total shareholder return of a 23.83% decline, suggesting fading momentum despite the recent 30 day...

Quarterly results and dividend announcement set fresh context for U.S. Physical Therapy U.S. Physical Therapy (USPH) reported first quarter 2026 revenue of US$198.29 million, compared with US$183.79 million a year earlier. Net income was US$5.04 million, versus US$9.9 million in the prior-year period, alongside a reaffirmed quarterly dividend. See our latest analysis for U.S. Physical Therapy. The earnings release appears to have reset expectations, with the stock’s 1 day share price return...

STAG Industrial (STAG) is back in focus after first quarter earnings showed higher revenue alongside lower net income and earnings per share, paired with steady leasing comments and a reaffirmed cash dividend. See our latest analysis for STAG Industrial. STAG Industrial’s US$38.67 share price reflects a modest 3.98% 1 month share price return and a 4.74% year to date share price return, while the 1 year total shareholder return of 18.62% points to momentum that has built over a longer stretch...

United Community Banks (UCB) is in focus after recent trading showed a mix of short term gains and pullbacks. This has prompted investors to reassess the stock’s valuation and performance across different time frames. See our latest analysis for United Community Banks. With the share price at US$33.56, recent trading has been choppy, with a 1-day share price return of a 1.12% decline contrasting with a 30-day share price return of 3.39%. The 1-year total shareholder return of 21.08% and...

Royalty Pharma plc recently reported first-quarter 2026 results showing revenue of US$631 million and net income of US$295 million, both higher than a year earlier, alongside continued share repurchases under its existing buyback program. Beyond the headline numbers, the company highlighted double-digit growth in recurring royalty receipts, increased its dividend, and committed over US$1.25 billion to new royalty and R&D funding deals, underscoring its role as a large-scale financier of...

Inhibrx Biosciences (INBX) has drawn fresh attention after scheduling a May 11 webcast to share interim Phase 2 HexAgon data on its OX40 agonist INBRX-106 in first-line head and neck cancer. See our latest analysis for Inhibrx Biosciences. The webcast follows a sharp 30 day share price return of about 100% and a year to date gain of nearly 66%. However, the 1 day share price return shows a 12% decline, while the 1 year total shareholder return is around 10x. If this kind of clinical catalyst...

Beyond Meat has recently reported first-quarter 2026 results, with net revenues of US$58.21 million versus US$68.73 million a year earlier, and a reduced net loss of US$28.48 million, while also completing follow-on equity offerings and filing a US$10.40 million shelf registration tied to employee stock plans. Alongside cost cuts and lower cash use, the company is pivoting beyond plant-based meat into functional food and beverages, including its new Beyond Immerse protein drink distributed...

PennyMac Financial Services (PFSI) drew fresh attention after first quarter 2026 results showed net income of US$82.32 million and higher earnings per share, alongside continued share buybacks and an affirmed quarterly dividend. See our latest analysis for PennyMac Financial Services. The stock has been under pressure, with a year to date share price return of negative 32.58% and a 1 year total shareholder return of negative 8.83%. However, the 3 year and 5 year total shareholder returns of...

Qorvo (QRVO) has jumped onto investor radars after reporting quarterly results that beat revenue and adjusted EPS expectations, and after completing a large share repurchase that reduced outstanding stock during the period. See our latest analysis for Qorvo. Qorvo's latest beat on revenue and adjusted EPS, alongside the completed buyback, comes after a 14.39% 1 month share price return. The 1 year total shareholder return of 22.94% contrasts with weaker multi year results, suggesting...

Stock performance snapshot and recent context McGraw Hill (MH) has drawn attention after recent trading, with the stock closing at $11.99 and showing a 2.39% gain over the past day, while month and past 3 months returns remain negative. See our latest analysis for McGraw Hill. That daily 2.39% share price return comes after a tougher period, with the 30 day share price return of 10.92% and year to date share price return of 26.67% both negative. This suggests momentum has been fading rather...

JBT Marel Corporation recently reported first-quarter 2026 results showing sales of US$936 million, a return to net income of US$45 million, and positive earnings per share from continuing operations, while reiterating full-year 2026 revenue and GAAP diluted EPS guidance. Alongside these financial updates, JBT Marel is pushing into the foodservice channel with its award-winning Fresh’n Squeeze 1800 Citrus Juicer, highlighting how its industrial processing expertise can be repurposed for...

In late April 2026, Tanger Inc. reported first-quarter results showing year-over-year increases in sales to US$143.54 million, revenue to US$150.42 million, and net income to US$28.26 million, while also completing a US$20.00 million repurchase of 589,622 shares and slightly raising its full-year diluted EPS guidance to US$1.05–US$1.13. Beyond the headline growth figures, the combination of higher quarterly earnings per share, an active buyback, and a guidance upgrade highlights Tanger’s...

Laureate Education, Inc. has reported past first-quarter 2026 results, with sales rising to US$272.61 million while its net loss widened to US$21.59 million, and the company has also issued second-quarter 2026 revenue guidance of US$597 million to US$601 million while reaffirming full-year expectations of about US$1.89 billion to US$1.91 billion. The combination of higher quarterly sales and reaffirmed full-year revenue guidance offers investors fresh information on how Laureate’s operations...

Guidance raise and first quarter earnings put Ventas in focus Ventas (VTR) raised its full year 2026 earnings guidance and reported first quarter results, highlighting higher property performance in its senior housing portfolio and contributions from recent investment activity. See our latest analysis for Ventas. After the guidance raise and first quarter results, Ventas’s recent share price moves tell a story of steady interest, with a 30 day share price return of 3.5%, year to date share...

RadNet (RDNT) has drawn fresh attention after forming a joint venture with Saint Alphonsus Health System in Idaho, acquiring a majority stake in Intermountain Medical Imaging and preparing to report upcoming first quarter earnings. See our latest analysis for RadNet. Despite the Idaho joint venture and ongoing focus on AI-enabled imaging, RadNet’s share price return has been weak year to date, with a 19% decline and a 17% 3 month pullback, even as the 1 year total shareholder return is...

Capital One Financial (COF) is back in focus after reporting Q1 2026 revenue and earnings below expectations, as rising loan-loss provisions and charge-offs highlighted mounting consumer stress and prompted several analysts to trim their forecasts. See our latest analysis for Capital One Financial. The stock’s recent pullback has been sharp, with a 22.32% year to date share price return decline and a 13.56% 3 month share price return decline. This comes even though the 3 year total...

Earlier this month, Charter Communications’ Spectrum brand launched Spectrum Mobile Second Line, a US$10-per-month add-on that lets eligible Dual SIM and dual eSIM smartphone users run two separate mobile numbers with shared data, unified billing, and full calling features across the U.S., Mexico, and Canada. A day earlier, Spectrum reshaped its product leadership by promoting long-time executive Dave Rodrian to Senior Vice President of Connectivity Products, consolidating oversight of...